Betatrophin: A Novel Biomarker For Obstructive Sleep Apnea And Dyslipidemia
Obstructive sleep apnea (OSA) is a well-known public health problem, with high prevalence and numerous complications, such as excessive daytime sleepiness and lack of focus, which impact the daily ac
Metabolomics At DDI
Dasman Diabetes Institute (DDI) has been recognized regionally and internationally as a leading research institute in metabolic diseases. To better understand the role of various metabolites in the d
Times-DDI hosts the ‘Collaborative Advantage’ Symposia
Kuwait Times-DDI Sanofi host workshop
Arab Times-DDI embarks on scientific innovation
DDI embarks on scientific innovation initiative
Meet The CSO
PROF. FAHD AL-MULLA CSO at Dasman Diabetes Institute As the Chief Scientific Officer (CSO), Professor Fahd Al-Mulla steers the research activities carried out at DDI, providing direction and focu